IMMUNOTHERAPY WITH THE TRIFUNCTIONAL ANTIBODY FBTA05 IN PEDIATRIC HIGH RISK PATIENTS WITH RECURRENT CD20 POSITIVE B CELL MALIGNANCIES - A CLINICAL FOLLOW UP

被引:0
|
作者
Buhmann, R. [1 ]
Schuster, F. [2 ]
Stanglmaier, M. [3 ]
Woessmann, W. [4 ]
Winkler, B. [5 ]
Meisel, R. [2 ]
Ruf, P. [3 ]
Schlegel, P. G. [5 ]
Lindhofer, H. [3 ]
Reiter, A. [4 ]
Borkhardt, A. [2 ]
Buhmann, R. [1 ]
机构
[1] Klinikum LMU, Med Klin 3, Munich, Germany
[2] Heinrich Heine Univ, Dept Paediat Oncol, Dusseldorf, Germany
[3] TRION Res GmbH, Martinsried, Germany
[4] Justus Liebig Univ, Dept Paediat Haematol, Giessen, Germany
[5] Julius Maximilians Univ, Dept Paediat Haematol, Wurzburg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1156
引用
收藏
页码:479 / 479
页数:1
相关论文
共 28 条
  • [1] Clinical follow-up of paediatric high-risk patients with recurrent CD20 positive B-cell malignancies treated with the trifunctional antibody FBTA05 (anti-CD3 x anti-CD20)
    Schuster, F.
    Stanglmaier, M.
    Woessman, W.
    Winkler, B.
    Ruf, P.
    Schlegel, P.
    Meisel, R.
    Lindhofer, H.
    Borkhardt, A.
    Buhmann, R.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S456 - S456
  • [2] Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies
    Schuster, Friedhelm R.
    Stanglmaier, Michael
    Woessmann, Wilhelm
    Winkler, Beate
    Siepermann, Meinolf
    Meisel, Roland
    Schlegel, Paul G.
    Hess, Juergen
    Lindhofer, Horst
    Borkhardt, Arndt
    Buhmann, Raymund
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 90 - 102
  • [3] Immunotherapy with FBTA05 (Bi20), a trifunctional anti-CD3 x anti-CD20 antibody in recurrent childhood B-cell malignancies
    Schuster, F.
    Stanglmaier, M.
    Woessmann, W.
    Winkler, B.
    Meisel, R.
    Schlegel, P. G.
    Lindhofer, H.
    Reiter, A.
    Borkhardt, A.
    Buhmann, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S247 - S247
  • [4] IMMUNOTHERAPY OF RECURRENT B-CELL MALIGNANCIES IN ADULT AND PAEDIATRIC PATIENTS WITH FBTA05, A TRIFUNCTIONAL ANTIBODY (ANTI-CD3 X ANTI-CD20) AND ALLOGENEIC DONOR LYMPHOCYTE INFUSION
    Buhmann, R.
    Stanglmaier, M.
    Schuster, F.
    Simoes, B.
    Menzel, H.
    Ruf, P.
    Peschel, C.
    Lindhofer, H.
    Borkhardt, A.
    Kolb, H. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 183 - 183
  • [5] Adoptive immunotherapy of recurrent B-cell malignancies after allogeneic stem cell transplantation with Bi20 (FBTA05) a CD3xCD20 trifunctional antibody and donor lymphocyte transfusion
    Buhmann, R.
    Simoes, B.
    Stanglmaier, M.
    Yang, T.
    Faltin, M.
    Bund, D.
    Lindhofer, H.
    Kolb, H. -J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S45 - S45
  • [6] Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 × anti-CD20 antibody and donor lymphocyte infusion
    R Buhmann
    B Simoes
    M Stanglmaier
    T Yang
    M Faltin
    D Bund
    H Lindhofer
    H-J Kolb
    Bone Marrow Transplantation, 2009, 43 : 383 - 397
  • [7] Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion
    Buhmann, R.
    Simoes, B.
    Stanglmaier, M.
    Yang, T.
    Faltin, M.
    Bund, D.
    Lindhofer, H.
    Kolb, H-J
    BONE MARROW TRANSPLANTATION, 2009, 43 (05) : 383 - 397
  • [8] Immunotherapy with the trifunctional anti-CD20xanti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease
    Kieslich, Anna
    Ruf, Peter
    Lindhofer, Horst
    Buhmann, Raynold
    Eggert, Angelika
    Hundsdoerfer, Patrick
    LEUKEMIA & LYMPHOMA, 2017, 58 (08) : 1989 - 1992
  • [9] Bi20 (FBTA05), a novel trifunctional bispecific antibody (anti-CD20 x anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels
    Stanglmaier, Michael
    Faltin, Margot
    Ruf, Peter
    Bodenhausen, Annette
    Schroeder, Petra
    Lindhofer, Horst
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1181 - 1189
  • [10] A New Human CD20 Spliced mRNA as a Potential Molecular Marker for the Follow-up of B-Cell Malignancies.
    Deschamps, Marina
    Henry, Carole
    Robinet, Eric
    Garnache-Ottou, Francine
    Remy-Martin, Jean-Paul
    Borg, Christophe
    Rohrlich, Pierre-Simon
    Deconinck, Eric
    Tiberghien, Pierre
    Ferrand, Christophe
    BLOOD, 2008, 112 (11) : 526 - 526